Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 266 | $122,323,899 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 08 Feb 2024 | Sale | 500 | 945 | 472,500 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 09 Feb 2024 | Sale | 500 | 955 | 477,500 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 512 | 959.36 | 491,192 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 23 Feb 2024 | Sale | 500 | 985 | 492,500 | D |
28 Feb 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 26 Feb 2024 | Sale | 500 | 990 | 495,000 | D |
28 Feb 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 26 Feb 2024 | Sale | 500 | 995 | 497,500 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 617 | 842.66 | 519,921 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 545 | 955.54 | 520,769 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 625 | 836.32 | 522,700 | D |
14 Dec 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 13 Dec 2023 | Sale | 610 | 870 | 530,700 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 576 | 953.77 | 549,372 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 667 | 838.37 | 559,193 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 601 | 949.45 | 570,619 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 600 | 955 | 573,000 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 620 | 944.3 | 585,466 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 752 | 794.57 | 597,517 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 759 | 843.31 | 640,072 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 22 Aug 2023 | Sale | 782 | 842.16 | 658,569 | D |
11 Aug 2023 16:13 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 10 Aug 2023 | Sale | 853 | 789 | 673,017 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 829 | 816.46 | 676,845 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 730 | 957.35 | 698,866 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 877 | 801.56 | 702,968 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 750 | 939.6 | 704,700 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 21 Aug 2023 | Sale | 853 | 829 | 707,137 | D |
04 Jan 2024 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 03 Jan 2024 | Sale | 826 | 914 | 754,964 | D |
02 Nov 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Nov 2023 | Sale | 1,000 | 783.91 | 783,910 | D |
31 Jan 2024 16:52 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 30 Jan 2024 | Sale | 827 | 959 | 793,093 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 973 | 819.57 | 797,442 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 870 | 954.66 | 830,554 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 26 Feb 2024 | Sale | 854 | 979.25 | 836,280 | D |
17 Oct 2023 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | ZOGHBI HUDA Y | Director | 13 Oct 2023 | Sale | 1,000 | 850 | 850,000 | D |
03 Oct 2023 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 02 Oct 2023 | Sale | 1,038 | 827 | 858,426 | D |
06 Feb 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 05 Feb 2024 | Sale | 1,000 | 934.71 | 934,710 | D |
09 Feb 2024 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | LAROSA JOSEPH J | EVP General Counsel and Secret | 07 Feb 2024 | Sale | 1,000 | 950 | 950,000 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 22 Feb 2024 | Sale | 1,000 | 960 | 960,000 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 22 Feb 2024 | Sale | 1,000 | 965 | 965,000 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LAROSA JOSEPH J | EVP General Counsel and Secret | 22 Feb 2024 | Sale | 1,000 | 967.65 | 967,650 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 22 Feb 2024 | Sale | 1,000 | 970 | 970,000 | D |
28 Feb 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LAROSA JOSEPH J | EVP General Counsel and Secret | 26 Feb 2024 | Sale | 1,000 | 990 | 990,000 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 1,046 | 952.62 | 996,441 | D |
04 Jan 2024 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | ZOGHBI HUDA Y | Director | 02 Jan 2024 | Sale | 1,117 | 900 | 1,005,300 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 1,059 | 952.49 | 1,008,687 | D |
26 Dec 2023 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 21 Dec 2023 | Sale | 1,224 | 844.09 | 1,033,166 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 1,100 | 954.57 | 1,050,027 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 1,108 | 956.34 | 1,059,625 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 1,333 | 818.59 | 1,091,180 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 1,237 | 951.49 | 1,176,993 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 1,342 | 953.47 | 1,279,557 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 1,601 | 799.48 | 1,279,967 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 1,614 | 798.63 | 1,288,989 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 1,881 | 817.36 | 1,537,454 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 1,998 | 838.6 | 1,675,523 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 1,894 | 948.69 | 1,796,819 | D |
29 Dec 2023 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 27 Dec 2023 | Sale | 2,049 | 898 | 1,840,002 | D |
29 Dec 2023 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 27 Dec 2023 | Sale | 2,448 | 856.71 | 2,097,226 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 2,534 | 844.27 | 2,139,380 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 2,691 | 943.51 | 2,538,985 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 3,032 | 839.45 | 2,545,212 | D |
25 Jan 2024 16:18 | REGN | REGENERON PHARMACEUTICALS Inc | GOLDSTEIN JOSEPH L | Director | 23 Jan 2024 | Sale | 2,707 | 950 | 2,571,650 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 3,127 | 950.43 | 2,971,995 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 22 Aug 2023 | Sale | 4,574 | 841.41 | 3,848,609 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 4,261 | 940.44 | 4,007,215 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 22 Aug 2023 | Sale | 6,309 | 840.53 | 5,302,904 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 6,450 | 840.65 | 5,422,192 | D |
04 Jan 2024 16:20 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 02 Jan 2024 | Sale | 16,848 | 900 | 15,163,200 | I |
01 May 2024 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 02 Jan 2024 | Sale | 16,848 | 900 | 15,163,200 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)